Galectin Therapeutics director Harold Shlevin purchases $7,539 in common stock By Investing.com
NORCROSS, Ga.โHarold H. Shlevin, a director at Galectin Therapeutics Inc. (NASDAQ:), has boosted his investment in the company by acquiring 6,500 shares of common stock. This purchase, conducted on